Highmark Health, Allegheny Health Network and Torax Medical Partner to Explore Cost-Effectiveness of New Procedure to Treat Gastro-esophageal Reflux Disease (GERD)
The VITAL innovation program is a formal, rapid and competitive review and funding process open to innovators who wish to test new ideas to improve the quality and affordability of care.
"This collaboration aligns with our mission to be a value-based health provider," said
"Torax Medical and physician thought leaders have collaborated for over a decade building a strong scientific foundation of evidence to support the safety and efficacy of the LINX procedure. Today, we are excited to announce this partnership with
An estimated 1 in 5 U.S. adults suffer from GERD, a chronic, often progressive disease that can cause debilitating symptoms and in certain cases lead to esophageal cancer. GERD is caused by a weak esophageal sphincter muscle that fails to control reflux of harmful gastric fluids from the stomach into the esophagus. Until recently, the only available treatment is a more invasive procedure which requires a portion of the patient's stomach to be dissected and wrapped around the esophagus to restore the sphincter. The LINX System is a much less invasive procedure for the patient. It allows surgeons to leave the stomach intact by using a small device to augment the sphincter; typically patients go home the same day of the procedure.
LINX is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter's barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures. The LINX procedure does have potential risks, and contraindications.
According to Blair Jobe, MD Program Director and
About
About
About Torax Medical
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/highmark-health-allegheny-health-network-and-torax-medical-partner-to-explore-cost-effectiveness-of-new-procedure-to-treat-gastro-esophageal-reflux-disease-gerd-300139418.html
SOURCE



Advisor News
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
- America’s ‘confidence recession’ in retirement
More Advisor NewsAnnuity News
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
- Guaranty Income Life Marks 100th Anniversary
- Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
More Annuity NewsHealth/Employee Benefits News
- HEALTH INSURERS SHOW NO REMORSE FOR THE HELL THEY PUT PATIENTS THROUGH
- GOP HEALTH CARE CRISIS: FEWER MICHIGANDERS ARE ENROLLING IN AFFORDABLE CARE ACT HEALTH INSURANCE PLANS THIS YEAR
- NEW REPORT: UP TO 120,000 OHIOANS LOSE COVERAGE UNDER JON HUSTED'S HEALTH CARE CRISIS
- HEALTH SUBCOMMITTEE HOLDS HEALTH INSURANCE COMPANY CEOS ACCOUNTABLE FOR SKYROCKETING COSTS
- KELLY TO HEALTH INSURANCE CEOS: SUPPORT THE 'IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT'
More Health/Employee Benefits NewsLife Insurance News